INTRODUCTION
Cancer-related fatigue (CRF) is one of the most common symptoms experienced by cancer survivors irrespective of type of cancer or type of treatment. It is estimated that 25 to 90% of survivors experience fatigue sometime during the cancer continuum (1). The average prevalence is 48% but is greater with such cancers as pancreatic and breast and greater during treatment (13). The National Comprehensive Cancer Network (NCCN) defines CRF as “a distressing persistent, subjective sense of physical, emotional and/or cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional to recent activity